Print 
In our relentless focus on bringing beneficial new drugs to patients and to the market, we place a premium on establishing and maintaining an in-depth understanding of oncology research and development, and complement the experience of our internal team with expert opinions from key advisors in the research and medical communities. Our pipeline of promising anticancer medicines is enhanced by the high caliber science conducted by Sunesis researchers and our external collaborators.
Although cancer treatment remains a significant challenge, we are committed to pursuing hypothesis-based medicine in order to meet that challenge—and we have developed and are testing some very promising compounds, including our most advanced development candidate voreloxin.
